Unresectable Pleural or Peritoneal Malignant Mesothelioma research hub

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

This study is testing a new drug, tremelimumab, against a dummy treatment (placebo) for people with a type of cancer called malignant mesothelioma that cannot be removed by surgery. It aims to see if the new drug can help patients.